Rituxan-Induced Tumor Lysis Syndrome in a Patient With Diffuse Large B-Cell Lymphoma

Rituximab or Rituxan is a common drug used in the treatment of lymphomas. It is almost always used in conjunction with other chemotherapy regimens. Mechanism of action involves killing of the CD 20+ cells. Rituximab is implicated in precipitating tumor lysis syndrome (TLS) in patients with diffused...

Descripción completa

Detalles Bibliográficos
Autores principales: Iftikhar, Saffa, Khokher, Waleed, Gekonde, Joan, Kesireddy, Nithin, Mudiyanselage, Prabath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418554/
https://www.ncbi.nlm.nih.gov/pubmed/34513493
http://dx.doi.org/10.7759/cureus.16921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418554/
https://www.ncbi.nlm.nih.gov/pubmed/34513493
http://dx.doi.org/10.7759/cureus.16921

Ejemplares similares